Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: The ASPEN study - 15/01/15
, S. Zoppei b, C. Ferrari c, C. Bonetto b, T. Van Bortel d, G. Thornicroft e, L. Knifton f, N. Quinn f, G. Rossi a, A. Lasalvia bThe ASPEN Study group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Introduction |
Individual social capital has been recognized as having an important role for health and well-being. We tested the hypothesis that poor social capital increases internalized stigma and, in turn, can reduce empowerment among people with major depressive disorder (MDD).
Materials and methods |
This is a cross-sectional multisite study conducted on a sample of 516 people with MDD in 19 European countries. Structural Equation Models were developed to examine the direct and indirect effects of self-stigma and social capital on empowerment.
Results |
Social capital and self-stigma accounted for 56% of the variability in empowerment. Higher social capital was related to lower self-stigma (r=–0.72, P<0.001) which, in turn, partially mediated the relationship between social capital and empowerment (r=0.38, P<0.001).
Conclusions |
Social capital plays a key role in the appraisal of empowerment, both directly and through the indirect effect mediated by self-stigma. In order to improve empowerment of people with MDD, we identify strategies to foster individual social capital, and to overcome the negative consequences related to self-stigma for attainment of life goals.
Le texte complet de cet article est disponible en PDF.Keywords : Self-stigma, Depression, Empowerment, Social capital
Plan
Vol 30 - N° 1
P. 58-64 - janvier 2015 Retour au numéro
Article précédent
- A 5-year prospective study of predictors for functional and work disability among primary care patients with depressive disorders
- K. Riihimäki, M. Vuorilehto, E. Isometsä
- Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial
- G. Scantamburlo, M. Hansenne, V. Geenen, J.J. Legros, M. Ansseau
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?